Economic and Clinical Impact of Optimizing Antimicrobial Stewardship Programs in U.S. Hospitals: A Comprehensive Review

Antimicrobial stewardship programs (ASPs) have become essential components of modern healthcare systems to combat the growing threat of antimicrobial resistance while optimizing patient outcomes. This paper examines the economic and clinical impact of optimizing ASPs in U.S. hospitals. A comprehensive literature review was conducted examining peer-reviewed studies published between 2010-2025 that evaluated the economic and clinical outcomes of ASP optimization in U.S. hospital settings. Studies were analyzed for implementation strategies, cost-effectiveness measures, clinical outcomes, and barriers to optimization. Results showed that optimized ASPs demonstrate significant economic benefits, with average cost savings of $732 per patient in U.S. studies (range: $2.50-$2,640) and annual hospital savings averaging $435,000. Clinical outcomes show consistent improvements, with 85% of studies reporting decreased length of stay and 14-92% reduction in antibiotic expenditure. Implementation of CDC Core Elements increased from 41% in 2014 to 91% in 2020, with prospective audit and feedback achieving 60-90% acceptance rates. In conclusion, optimized ASPs provide substantial value to U.S. hospitals through improved clinical outcomes and significant cost savings. The primary economic driver is a reduction in length of stay, while clinical benefits include decreased inappropriate antibiotic use, reduced healthcare-associated infections, and improved patient safety. Successful optimization requires comprehensive implementation of evidence-based strategies, adequate resources, and sustained leadership commitment.